表紙
市場調查報告書
商品編碼
975209

光學同調斷層掃瞄 (OCT) - 醫療設備的開發平台評估

Optical Coherence Tomography (OCT) Devices - Medical Devices Pipeline Assessment, 2020

出版日期: | 出版商: GlobalData | 英文 64 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供光學同調斷層掃瞄的開發中產品調查分析,以各開發階段比較分析為焦點,提供包含正開發管道產品的主要企業,進行中的臨床試驗相關之系統性資訊

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 光學同調斷層掃瞄 (OCT) - 開發中產品:各開發階段
  • 光學同調斷層掃瞄 (OCT) - 開發中產品:各地區
  • 光學同調斷層掃瞄 (OCT) - 開發中產品:各法規途徑
  • 光學同調斷層掃瞄 (OCT) - 開發中產品:各核准預定日
  • 光學同調斷層掃瞄 (OCT) - 進行中的臨床試驗

第4章 光學同調斷層掃瞄 (OCT) - 正在開發的管道產品:各企業

  • 光學同調斷層掃瞄 (OCT) 企業 - 開發中產品:各開發階段
  • 光學同調斷層掃瞄 (OCT) - 開發中產品:各開發階段

第5章 光學同調斷層掃瞄 (OCT) 企業與產品概要

  • Canon USA Inc
  • Carl Zeiss Meditec AG
  • Compact Imaging Inc.
  • Costruzioni Strumenti Oftalmici Cso Srl
  • Duke University
  • George Washington University
  • Heidelberg Engineering GmbH
  • Kubota Vision Inc
  • Leica Microsystems GmbH
  • Lumedica Inc
  • Moorfields Eye Hospital NHS Foundation Trust
  • Nippon Telegraph and Telephone Corp
  • Notal Vision Inc
  • OptoQuest Inc
  • Optos Plc
  • Optovue Inc
  • Praevium Research Inc.
  • Rowiak GmbH
  • Sinoora Inc.
  • University of California Berkeley
  • University of Illinois at Chicago
  • University of Liverpool
  • University of Pittsburgh
  • University of Rochester
  • University of Texas at Austin

第6章 光學同調斷層掃瞄 (OCT) - 最近的趨勢

第7章 附錄

目錄
Product Code: GDME1071EPD

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT) Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Optical Coherence Tomography (OCT) Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Optical Coherence Tomography (OCT) is a non-invasive imaging equipment which relies on low coherence interferometry to generate in-vivo, high resolution cross-sectional imagery of ocular tissues such as retina.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Optical Coherence Tomography (OCT) Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Optical Coherence Tomography (OCT) Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Optical Coherence Tomography (OCT) Devices Overview

3 Products under Development

  • 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory
  • 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
  • 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
  • 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials

4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies

  • 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
  • 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development

5 Optical Coherence Tomography (OCT) Companies and Product Overview

  • 5.1 Canon USA Inc Company Overview
    • 5.1.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Carl Zeiss Meditec AG Company Overview
    • 5.2.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Compact Imaging Inc. Company Overview
    • 5.3.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
    • 5.4.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Duke University Company Overview
    • 5.5.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 George Washington University Company Overview
    • 5.6.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Heidelberg Engineering GmbH Company Overview
    • 5.7.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Kubota Vision Inc Company Overview
    • 5.8.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Leica Microsystems GmbH Company Overview
    • 5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Lumedica Inc Company Overview
    • 5.10.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Moorfields Eye Hospital NHS Foundation Trust Company Overview
    • 5.11.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Nippon Telegraph and Telephone Corp Company Overview
    • 5.12.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Notal Vision Inc Company Overview
    • 5.13.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 OptoQuest Inc Company Overview
    • 5.14.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Optos Plc Company Overview
    • 5.15.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Optovue Inc Company Overview
    • 5.16.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Praevium Research Inc. Company Overview
    • 5.17.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Rowiak GmbH Company Overview
    • 5.18.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Sinoora Inc. Company Overview
    • 5.19.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of California Berkeley Company Overview
    • 5.20.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 University of Illinois at Chicago Company Overview
    • 5.21.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 University of Liverpool Company Overview
    • 5.22.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 University of Pittsburgh Company Overview
    • 5.23.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 University of Rochester Company Overview
    • 5.24.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 University of Texas at Austin Company Overview
    • 5.25.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview

6 Optical Coherence Tomography (OCT)- Recent Developments

  • 6.1 Jul 29, 2020: Kubota Vision demonstrates 3D imaging capabilities using AI on PBOS
  • 6.2 Jun 29, 2020: Abbott's imaging altered treatment course in 88% of artery blockages
  • 6.3 Apr 15, 2020: High-res imaging with elastography may accurately detect breast cancer in surgical margins
  • 6.4 Apr 15, 2020: High-resolution imaging coupled with elastography may accurately detect breast cancer in surgical margins
  • 6.5 Apr 13, 2020: Breakthrough technology used to discover eye damage from repeated intravitreal injections
  • 6.6 Feb 28, 2020: Leica Microsystems announces new market representation for Mid-Atlantic medical market
  • 6.7 Feb 19, 2020: Conavi Medical and Japan Lifeline announce MHLW approval of Novasight Hybrid Intravascular Imaging System for Japanese market
  • 6.8 Feb 19, 2020: Duke University and Leica Microsystems establish Center of Excellence in Microscopy
  • 6.9 Feb 11, 2020: AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics
  • 6.10 Jan 28, 2020: Artificial intelligence predicts treatment outcome for diabetes-related vision loss

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Table 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
  • Table 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
  • Table 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
  • Table 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
  • Table 6: Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
  • Table 7: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Table 8: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: SPOCT HR - Product Status
  • Table 10: SPOCT HR - Product Description
  • Table 11: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: ZEISS CIRRUS 6000 - Product Status
  • Table 13: ZEISS CIRRUS 6000 - Product Description
  • Table 14: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: MRO Optical Imaging Sensor - Product Status
  • Table 16: MRO Optical Imaging Sensor - Product Description
  • Table 17: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: MD-SD-OCT Instrument - Product Status
  • Table 19: MD-SD-OCT Instrument - Product Description
  • Table 20: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: HH - SDOCT - Product Status
  • Table 22: HH - SDOCT - Product Description
  • Table 23: Microscope Integrated OCT System - Product Status
  • Table 24: Microscope Integrated OCT System - Product Description
  • Table 25: Whole Eye Optical Coherence Tomography Scanner - Product Status
  • Table 26: Whole Eye Optical Coherence Tomography Scanner - Product Description
  • Table 27: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Amplified Bimorph Scanning Mirror System - Product Status
  • Table 29: Amplified Bimorph Scanning Mirror System - Product Description
  • Table 30: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Cataract And Refractive Imaging Device - Product Status
  • Table 32: Cataract And Refractive Imaging Device - Product Description
  • Table 33: SPECTRALIS OCT2 Module - OCT Angiography - Product Status
  • Table 34: SPECTRALIS OCT2 Module - OCT Angiography - Product Description
  • Table 35: Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Retinal Health Monitoring OCT System - Product Status
  • Table 37: Retinal Health Monitoring OCT System - Product Description
  • Table 38: Kubota Vision Inc - Ongoing Clinical Trials Overview
  • Table 39: Retinal Health Monitoring OCT System - Evaluation of the Retinal Health Monitoring System - Retinal Thickness Module in Subjects with Normal Macular Thickness and Subjects with Center-involving Macular Edema
  • Table 40: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: DI-SDOCT Imaging System - Product Status
  • Table 42: DI-SDOCT Imaging System - Product Description
  • Table 43: SDOCT Scanner - Product Status
  • Table 44: SDOCT Scanner - Product Description
  • Table 45: Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Optical Coherence Tomography System - Product Status
  • Table 47: Optical Coherence Tomography System - Product Description
  • Table 48: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Binocular Optical Coherence Tomography - Product Status
  • Table 50: Binocular Optical Coherence Tomography - Product Description

List of Figures

List of Figures

  • Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
  • Figure 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
  • Figure 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
  • Figure 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
  • Figure 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials